Mega-goiter is defined as an enlargement of the thyroid gland that is not caused by inflammation of cancer. Mega-goiters are challenging to remove surgically. Most of these patients have had their goiters for many years, but for whatever reason, including access to specialty care, fear, or lack of education, many of these patients fail to have them surgically removed earlier. As such, these thyroid glands continue to grow to enormous size, and theoretically, it should be more costly to provide care to these patients than to nongoiter patients.
Many of these patients have lived in endemic areas, where there is an absence of iodine in the diet, and where the thyroid gland cannot produce enough thyroid hormone to meet the body's daily requirement. Therefore, iodine is stored rather than released, and the thyroid gland enlarges.
In this review, we will present several cases of megagoiters, but we will also try to analyze the data in hcupnet .ahrg.gov and other data banks to determine an average cost of a standard thyroidectomy versus the cost involved with the care of patients presenting with mega-goiters.
Telemedical Fitting of Cochlear implantation Patients in Kyrgyzstan
Piotr H. Skarzynski (presenter); Maciej Ludwikowski, MBA; Adam Walkowiak, PhD, MSc; Henryk Skarzynski, MD, PhD
Objectives: To obtain the best hearing benefits after cochlear implantation, the speech processor must be optimally fitted. Most patients who have been implanted are unable to receive correct implant fitting. They have to undertake a long trip to the cochlear implant clinic, and this incurs high cost, time, and travel weariness. To overcome this problem, "telefitting" has been proposed. The center in Kyrgyzstan is sufficiently equipped; however, programming of the cochlear implant system cannot be conducted by the team there because of a lack of trained specialists and limited experience. The aim of this poster is to present the usage of telefitting between Poland and Kyrgyzstan.
Methods: The Internet allows specialists from Poland to set up a teleconference for audio and video contact with the patient and support specialist and allows remote desktop software to access a remote computer and perform fitting. Every node is equipped with teleconference terminals from Polycom Inc with LCD screens and zoomable and movable Polycom cameras, connected to a system with symmetric Internet connections. There is also a PC computer equipped with clinical interface boxes with appropriate fitting software. The LogMeIn application is used for remote control.
Results and Conclusions: The method and a proposed model of postoperative care for implanted patients using telemedicine seem to be reliable alternatives to the standard model. They improve the quality of service provided to patients and saves substantial time and money. The telefitting model increased accessibility to hearing care services in Kyrgyzstan. Presentation schedule is subject to change. The Official Program Abstracts supplement does not reflect changes made after August 17, 2017. Background: While most differentiated thyroid cancers have an excellent prognosis when treated with surgery and radioactive iodine ablation (RAI), there exist a small percentage of patients with unresectable and/or metastatic disease that is not responsive to RAI. For these patients, antiangiogenic tyrosine kinase inhibitors (TKIs) have been introduced as the standard of care. However, severe and fatal side effects due to toxicity of TKI therapy have been reported.
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Objectives: To report a case of fatal side effects due to toxicity of TKI therapy.
Methods: We present a case of a 55-year-old man with unresectable, recurrent papillary thyroid cancer and pulmonary metastases previously treated with surgery and external beam radiation.
Results: The patient was initiated on lenvatinib and had dramatic involution of his tumor; however, this resulted in an extensive necrotic ulcer in his anterior neck extending from the site of his tracheostomy. Despite management with debridement and a pectoralis muscle flap, the patient ultimately suffered a fatal carotid blowout.
Conclusions: The possibility of severe side effects such as aerodigestive fistula formation and hemoptysis has been previously reported in patients undergoing treatment with TKIs. This is the first report of carotid blowout as a complication of TKI therapy. Risk factors for vascular compromise such as previous radiation therapy and invasion of the great vessels in the neck should warrant careful consideration prior to initiating therapy with antiangiogenic TKIs. In addition, close monitoring of the tumor bed for involvement of nearby vital structures should be performed while patients are on therapy.
Case Report of Multiple Thyroid Abnormalities and Papillary Thyroid Carcinoma
Steven B. Micucci, MD (presenter); Brian Song, MD; Deepak Gurushanthaiah, MD Objectives: To appreciate the embryologic development of the thyroid gland and to review the appropriate workup, management, and available literature concerning papillary thyroid carcinoma (PTC) within ectopic thyroid gland.
Methods: Here we discuss the case of a 49-year-old man who presented to a tertiary care center with regionally metastatic stage IVA (T3N1bM0) PTC originating from a thyroglossal duct remnant, while also possessing healthy lingual thyroid tissue and no orthotopic thyroid gland within the thyroid bed. The patient underwent surgical excision in September 2016.
Results: The patient presented with 1 year of enlarging neck mass and hypothyroidism. Physical examination was notable for a large, firm, midline neck mass above the level of the expected thyroid isthmus. Thyroid ultrasound revealed an approximately 6-cm heterogeneous mass and several concerning lymph nodes in left level IV. In office, fine-needle aspiration of the thyroid was positive for malignant PTC. The patient was surgically treated, where a 6-cm mass was found splaying the strap muscles at the midline raphe and closely associated with the hyoid bone, thyroid cartilage, and platysma. Additional findings include a 2-cm discrete undescended lingual thyroid and no thyroid within the normal paratracheal location. Total thyroidectomy, Sistrunk procedure, and left central and selective neck dissection were performed.
Conclusions: Errors in the embryologic development of the thyroid gland are common, though it is much less common for multiple abnormalities to be seen simultaneously, along with carcinomatous changes. We review the literature and discuss the workup and management of PTC in this context.
Effect of Bevacizumab on Thyroid Volume and Vascularity
Aaron M. Smith, MD (presenter); Courtney Shires, MD; Christopher Vanison, MD; John Boughter Jr, PhD; Vikrum Thimmappa, MD; Merry Sebelik, MD Objectives: Several clinical conditions increase thyroid gland volume and vascularity. Bevacizumab has been observed to reduce thyroid function, possibly through its effect on gland angiogenesis. This study aims to determine if bevacizumab has any effect on thyroid vascularity as measured by gland volume and superior thyroid artery (STA) flow velocity in the normal rat thyroid.
Methods: Twelve adult female Sprague-Dawley rats underwent baseline thyroid gland measurements. After induction of anesthesia, Vevo 2100 high-frequency ultrasound at 40 mHz was used to obtain STA flow measurements and thyroid gland dimensions. Six rats received intrathyroidal (IT) injections and 6 received intraperitoneal (IP) injections of bevacizumab (4-5 mg/kg). After 2 weeks, ultrasound measurements were repeated.
Results: Pretreatment animals displayed similar thyroid volume and vascularity. Thyroid volume decreased (62.6 vs 42.2, P < .004) after IP administration of bevacizumab, and blood flow measurements did not change. IT bevacizumab did not change thyroid volume (55.2 vs 58.2, P < .64). The average peak (73.2 vs 100.6 cm/s, P < .03) and mean (45.0 vs 62.8 m/s, P < .03) velocities were increased but did not differ in the Resistive Index (peak -end diastolic velocities/peak velocity, 0.62 vs 0.63).
Conclusions: Systemic administration of bevacizumab appears to decrease thyroid volume without an effect on STA flow. Further, ultrasound appears to be an effective tool for translational study of interventions in thyroid conditions affecting thyroid volume and vascularity, such as iodine deficiency, Grave's disease, and hypothyroidism.
Extramedullary Plasmacytoma of the Thyroid Gland
Phillip K. Pellitteri, DO (presenter); James Biery Background: Primary extramedullary plasmacytoma of the thyroid gland is a rare disease. Fewer than 100 patients with this unique neoplasm have been reported in the literature,
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Poster Presentations P177 many of whom were initially confused with other atypical thyroid neoplasms. The clinical and pathologic features have not been fully described and cataloged in the endocrine surgical community, especially with respect to potential association with the development of systemic multiple myeloma and proposal of a comprehensive management strategy.
Objectives: (1) Describe the clinical and pathological features of extramedullary plasmacytoma of the thyroid gland and catalog with respect to potential association with the development of systemic multiple myeloma. (2) Propose a comprehensive management strategy.
Methods: This discussion presents a patient with extramedullary plasmacytoma of the thyroid gland, initially evaluated for severe compressive thyromegaly due to Hashimoto's thyroiditis, and subsequently treated with surgical resection and combined chemotherapy and external beam radiotherapy. Described in the presentation are the clinical characteristics of the patient; the diagnostic workup, especially as it relates to the application and potential limitations of fine-needle aspiration cytology; and the treatment protocol administered. A management scheme will be highlighted, with respect to the potential presence of multiple myeloma in such patients and with a focus on a multimodality treatment strategy.
Results: Described in the presentation are the clinical characteristics of the patient; the diagnostic workup, especially as it relates to the application and potential limitations of fine-needle aspiration cytology; and the treatment protocol administered.
Conclusions: The clinical scenario of accelerated development of thyromegaly should prompt consideration of nonthyroid neoplastic disease (ie, lymphoma, extramedullary plasmacytoma). Fine-needle aspiration may not prove useful in securing a tissue diagnosis. Management in these circumstances should include an investigation for the presence of systemic disease. Most patients will require multimodality therapy.
Functional inferior Laryngeal Paraganglioma
Tsung-yen Hsieh, MD (presenter); Raj Dedhia, MD; Arnaud Bewley, MD Background: Paragangliomas are rare neuroendocrine tumors that are generally slow growing and benign. Head and neck paragangliomas account for approximately 3% of all paragangliomas and rarely involve the larynx. Laryngeal paragangliomas typically arise from superior paraganglion and less commonly from inferior paraganglion.
Objectives: To report on a rare case of a functional inferior laryngeal paraganglioma with extension through the thoracic inlet.
Methods: We report a 58-year-old female patient who was incidentally found to have a left-sided paratracheal neck mass extending into the superior mediastinum on imaging.
Results: The mass was initially thought to be an atypical carcinoid tumor; however, final surgical pathology after successful resection of the tumor via a transcervical approach determined the diagnosis to be a functional inferior laryngeal paraganglioma.
Conclusions: To our knowledge, this is the first reported case of a functional inferior laryngeal paraganglioma with extension through the thoracic inlet.
Giant Parathyroid Adenoma: it is Huge
Shayanne A. Lajud, MD (presenter); Fernando Morell, MD; Enrique Gorbea; Yamil Castillo, MD Objectives: To review the presentation, natural history, diagnosis, and management of giant parathyroid adenomas and to consider the implications of surgical treatment.
Methods: Case report and literature review.
Results: A 62-year-old woman with stage 3 chronic kidney disease, hypertension, and depression was referred to our head and neck surgery clinic for symptomatic severe hypercalcemia (15.0 mg/dL), hyperparathyroidism (parathyroid hormone level, 2727 pg/mL), and a palpable mass at the base of the right neck. Ultrasound revealed a large mass (4.4 × 2.6 cm) at the inferior aspect of the right thyroid lobe. Magnetic resonance imaging showed a T2-hyperintense, T1-hypointense 2.8-× 2.1-× 4.0-cm heterogeneous lesion at the posterior-inferior margin of the right thyroid lobe. Fine-needle aspiration showed atypical cytomorphic features of parathyroid tissue origin. These findings suggested a parathyroid malignancy. The patient was taken to the operating room, where a large parathyroid mass was identified extending to above the carotid and the retropharyngeal space displacing the thyroid to the right. A right parathyroidectomy and right hemithyroidectomy were performed. Her postoperative course was complicated by hungry bone syndrome, which required aggressive calcium and vitamin D supplementation. Pathology was consistent with a 5-× 3-cm giant parathyroid adenoma (GPA) weighing 17.4 g.
Conclusions: GPAs are rare benign causes of primary hyperparathyroidism and are typically asymptomatic. However, as illustrated in our case, GPAs may still present with severe symptomatic hyperparathyroidism. While surgical excision is indicated, patients should be monitored closely postoperatively for signs of hungry bone syndrome.
Hurthle Cell in Thyroid Fine-Needle Aspiration and Associated Malignancy Risk
Yin Ren, MD, PhD (presenter); Natalia Kyriazidis, MS; Dipti Kamani, MD; Nicole Torchia; William Faquin, MD, PhD; Gregory W. Randolph, MD Objectives: Hurthle cell/oncocytic change is commonly reported on fine-needle aspiration (FNA) cytology in patients with thyroid nodules. We evaluated the association between cytologic diagnoses containing Hurthle cells and pathology of the indexed thyroid nodule to identify cytologic factors associated with increased risk of malignancy in these nodules.
Methods: Retrospective review of 300 patients with Hurthle cell on FNA and surgical pathology at a tertiary center (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) . Factors including Bethesda cytologic classification and
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Results: FNAs included 14 (4.7%) nondiagnostic, 113 (38%) benign, 33 (11%) atypia of undetermined significance/ follicular lesion of undetermined significance (AUS/FLUS), 125 (42%) follicular neoplasm, 12 (4%) suspicious for malignancy, and 3 (1%) malignant. The rate of histopathologic malignancy was higher for suspicious or malignant than other categories (60% vs 14%, P = .0001). Focusing on the prevalence of Hurthle cell change, 69 (28%) were mild, 17 (6.9%) moderate, and 161 (65%) predominant. The rate of malignancy was higher in patients with predominant than either mild or moderate amounts of Hurthle cell change (22% vs 5.8%, P = .0006). In benign, AUS/FLUS, or follicular neoplasm FNAs, rate of malignancy increased when there was a predominance of Hurthle cell (20%-27%). A total of 251 patients (84%) had benign disease on final pathology. Hurthle cell adenoma was the most common benign diagnosis overall (44%) and in patients with predominant Hurthle cell on FNA (47%), whereas Hurthle cell carcinoma was the most common malignancy (47%).
Conclusions: Most Hurthle cell/oncocytic changes in FNA resulted in benign histology. The presence of predominant Hurthle cell increases the frequency of a malignant histopathologic diagnosis in certain Bethesda categories.
Low-Grade Thyroid Neoplasm with Anaplastic Features
Daniel B. Noel, MD (presenter); Jan Kasperbauer, MD; Michael Rivera, MD; Marius Stan, MD Objectives: Report a case of high-grade, poorly differentiated thyroid cancer discovered within an encapsulated, welldifferentiated neoplasm and review the current literature to generate management recommendations for this challenging pathologic finding.
Results: A 59-year-old man was referred for evaluation of a thyroid nodule. Nondiagnostic fine-needle aspiration was performed on the nodule, 3.7 cm in maximal dimension, and subsequent thyroid lobectomy revealed an encapsulated follicular neoplasm with a focus of high-grade carcinoma. The specimen was reviewed by an experienced pathologist at our institution, which receives a high volume of thyroid malignancies. The atypical cells showed evidence of necrosis and high mitotic activity and had a different panel of tumor markers than that of the well-differentiated component. The patient then underwent completion thyroidectomy and radioactive iodine treatment. A review of the literature reveals a paucity of data as they pertain to the incidence and management of this particular histopathologic finding.
Conclusions: Microscopic foci of poorly differentiated thyroid carcinoma within an encapsulated follicular neoplasm generate a diagnostic and therapeutic challenge given the heterogeneity of this rare histopathologic entity. A review of the PubMed database is discussed, which reveals a shortage of data as they pertain to the management of these neoplasms. The extent of surgery and the role of adjuvant therapy are not clearly defined in this setting.
Outcomes and Prognostic Factors in T4a
Thyroid Cancer Manki Chung, MD (presenter); Ji-Eun Choi, MD; Heejeong Kim, MD Objectives: The aim of this study is to present treatment outcomes and prognostic factors of surgical managements of locally advanced well-differentiated thyroid cancer.
Methods: By retrospective analysis, 70 patients with T4a stage were enrolled from 1995 to 2016 in a single institution. Overall survival rate and locoregional recurrence-free probability were investigated as treatment outcomes, and clinicopathologic characteristics were analyzed to investigate prognosticators for recurrence.
Results: The mean age of patients was 56.5 years, and 61.4% were female. The most commonly involved structure was recurrent laryngeal nerve (n = 35), followed by the trachea (n = 34), the larynx (n = 10), and the esophagus (n = 5). At the mean follow-up of 81.7 months, the 5-year disease-specific survival rate was 92.3%, and locoregional recurrence rate was 28.7%. By univariate analysis, microscopic clearance of tumor (R0 or R1) was not associated with increased risk of recurrence; on the contrary, advanced age, involvement of recurrent laryngeal nerve, increased tumor size, and higher level of stimulated serum thyroglobulin level at preablation and postablation state were associated with higher rate of locoregional recurrence. By univariate analysis, lateral node dissection was the prognostic factor for decreased rate of locoregional recurrence (hazard ratio 0.08, 95% confidence interval 0.01-0.48, P = .006).
Conclusions: Operative management followed by proper adjuvant therapy for locally advanced, differentiated thyroid cancer can achieve acceptable outcomes, regardless of the type of organs involved or R status. In addition, further studies to modify neck management strategy are needed.
Predicting Vocal Cord Recovery using Variations in intraoperative Nerve Monitoring
Vaninder K. Dhillon, MD (presenter); Ralph P. Tufano, MD, MBA Objectives: To demonstrate that variations in evoked potentials of the recurrent laryngeal nerve during thyroid surgery not only predict vocal cord immobility but prognosticate vocal cord recovery. In an anatomically intact nerve, there are certain patterns of change in threshold amplitude along the course of the nerve that can predict immobility as well as faster recovery. The value of intraoperative nerve monitoring (IONM) in thyroid surgery is not only in predicting immobility but also in vocal fold motion recovery.
Methods: Retrospective review of 7 patients who underwent partial or total thyroidectomy who experienced vocal
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Results: All 7 patients had vocal cord immobility postoperatively. Every recurrent laryngeal nerve was intact along its course intraoperatively. Intraoperative stimulus of the recurrent laryngeal nerve dropped >50% in all patients, and in 2 patients, proximal stimulus improved prior to the end of the case. Five of 7 patients had resolution of their vocal cord immobility after 6 to 8 weeks. One patient had vagal suprathreshold stimulus intraoperatively and this led to >6 months vocal cord immobility.
Conclusions: If vagal stimulus remained stable intraoperatively, a >50% drop in recurrent laryngeal nerve stimulus results in vocal cord immobility. Intraoperative resolution in the proximal stimulus resulted in faster vocal cord recovery. One patient had a vagal suprathreshold, and this also led to sustained vocal cord immobility.
Radioactive iodine in differentiated Thyroid Cancer
Ryan Orosco, MD (presenter); Julia Noel, MD; Yu-Jin Lee; Timon Hussain, MD; David Chang, PhD, MBA, MPH; Vasu Divi, MD; Lisa A. Orloff, MD Background: Radioactive iodine (RAI) is recommended for patients with high-risk differentiated thyroid cancer (DTC). Benefit in intermediate-and low-risk disease is less clear, and comparative data on RAI and survival in these subgroups are lacking.
Objectives: To quantify the therapeutic efficacy of RAI in DTC patient subgroups.
Methods: Population-based study was performed using the National Cancer Database (NCDB) from 2004 to 2012 and Surveillance, Epidemiology, and End Results (SEER) database from 1992 to 2009. Cox multivariate analyses were applied to 135 unique subgroups based on clinical and nonclinical parameters. Covariates included RAI, T/N/M stages, age, gender, and race. RAI usage, all-cause mortality (NCDB and SEER), and thyroid cancer-specific mortality (SEER) were determined.
Results: In multivariate analysis, RAI was associated with improved all-cause mortality in both NCDB (hazard ratio [HR] 0.55, P < .001) and SEER (HR 0.64, P < .001) and with thyroid cancer-specific mortality in SEER (HR 0.82, P = .029). Highrisk subgroups experienced the greatest all-cause mortality benefit, followed by intermediate risk and low risk. With regard to thyroid cancer-specific mortality, RAI was protective in highrisk subgroups and did not achieve statistical significance in most intermediate-risk subgroups. Low-risk T1a subgroups demonstrated increased thyroid cancer-specific mortality with RAI use (HR 7.89, P < .001).
Conclusions: Overall, RAI appears to be efficacious in patients with DTC. A graded effect was seen in various subgroups, with high-risk patients deriving the greatest survival benefit. The validity of the detrimental association between RAI in T1a subgroups and cancer-specific mortality is unclear but may suggest a contraindication for RAI usage in low-risk populations.
Reliability of Non-ultrasound-Guided Fine-Needle Aspiration in a developing Nation
Keshav Grover, DO, MS (presenter); Winston Jadusingh, PhD, MBBS; James Valenti, PhD; Samba S.R. Bathula, MD Background: Thyroid disease and head and neck masses present daily to the otolaryngologist. Timely diagnosis and treatment can pose a challenge to the practitioner, especially in the developing world.
Objectives: The aim of this paper is to examine the accuracy of fine-needle aspiration with cytology (FNAC) without ultrasound guidance compared with final histopathologic examination (HPE) correlation in West Jamaica.
Methods: We retrospectively reviewed charts from 1999 to 2009 at Cornwall Regional Hospital in Montego Bay, Jamaica. Patients with nodules less than 3 cm were excluded. Nonultrasound-guided fine-needle aspiration was performed by the on-staff otolaryngologist with cytology done by an on-site pathologist. FNAC results were compared with final HPE results.
Results: The rate of agreement between FNAC and HPE was high (90%) in the 414 charts examined. Among the 414 charts, 16 patients were diagnosed with a malignant disease on HPE. Among these 16 patients, 5 were incorrectly diagnosed on FNAC as benign. There was no relationship between correct identification of disease by FNAC and presence of a complication (correct identification of disease complication rate = 66.2%, noncorrect identification of disease complication rate = 61.2%, χ 2 = 0.62, P = .430).
Conclusions: Head and neck disease is difficult to identify in developing nations. In our review, non-ultrasound-guided FNAC for lesions 3 cm and larger proved to be accurate 90% of the time when compared with final HPE results. Our investigation provides an opportunity for the otolaryngologist to directly participate in the diagnosis of thyroid lesions. Further studies are needed to determine the safety profile, long-term consequences, and efficacy of our approach. Objectives: Approximately 50 cases of sclerosing mucoepidermoid carcinoma with eosinophilia (SMECE) of the thyroid gland have been reported in the literature. This traditionally "low-grade" tumor can prove to be diagnostically challenging and has recently been reported as displaying a more aggressive behavior. This study presents an aggressive case of SMECE as well as a review of the current literature.
Sclerosing Mucoepidermoid Carcinoma of the Thyroid Gland
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Methods: For each of the years available in the data set, the files were filtered to include 2 provider types: diagnostic radiology (DR) and otolaryngology (OTO-HNS). Billable procedures are listed by HCPCS code, and a filter was applied to include the following 3 codes: 76536 Ultrasound, soft tissues of the head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation; 76942 Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation; and 10022 Fine-needle aspiration, with imaging guidance.
Results: In 2014, otolaryngologists submitted charges for 13.6% of all 3 head and neck-related ultrasounds performed on Medicare beneficiaries. A total of 249 otolaryngologists submitted 4032 charges for 76532, 3045 charges for 10022, and 2779 charges for 76942. Individual otolaryngologists submitted 11 to 631 charges apiece, averaging 16 submitted charges per year. Ten percent of otolaryngologists submitted more than 100 charges during 2014, as compared with a smaller proportion of radiologists (3.6%) who did so.
Conclusions: Otolaryngologists accounted for over more than % of 685,985 head and neck-related ultrasound studies performed on Medicare beneficiaries in 2014. A greater proportion of otolaryngologists than radiologists (10% vs 3.6%) could be considered "super users," while the overall impact on total charges remained modest.
Vocal Cord Assessment for Endemic Goiter Surgery
Merry Sebelik, MD (presenter); Aaron M. Smith, MD; Jagdish K. Dhingra, MBBS; Jeremiah Tracy, MD Background and Objectives: Vocal cord mobility should be assessed before and after thyroid surgery. In some surgical settings around the world, the technology and/or skills necessary to view the glottis may be lacking. Mirror laryngoscopy is not possible in all patients; fiber-optic laryngoscopy (FOL) is considered the gold standard but is costly and may not be available. This study aims to determine the feasibility and utility of hand-held ultrasound to visualize vocal cord mobility.
Methods: In 2016, at a single institution, 24 consecutive patients underwent thyroid lobectomy for massive goiter. Hand-held ultrasound was used to view vocal cord mobility during the preoperative physical examination. It was again used within the first 24 hours after surgery to determine if it was an effective examination tool.
Results: All 24 patients were able to be visualized preoperatively and were noted to have bilaterally mobile vocal cords; 23 of 24 were able to be visualized postoperatively and were noted to have bilateral mobility. One patient was unable to be visualized but voice was unchanged from preoperative data.
Conclusions: While more costly than mirror laryngoscopy, hand-held ultrasound has a higher success rate and is less technique dependent. It is less costly and more portable than FOL and is readily cleaned between patients, whereas cleaning methods to ensure laryngoscope sterility are lacking in most austere settings. Hand-held ultrasonography proved to be an effective, rapid, and repeatable tool to perform preoperative and postoperative vocal cord assessments.
Facial Plastic and Reconstructive Surgery
3d Printing and Facial Trauma Phillip Lee, MD (presenter); Aaron Prussin, MD; Alison Crum, MD; Edward P. Quigley, III, MD, PhD
Objectives: (1) To describe a novel use for 3-dimensional (3D) printing in the management of facial trauma. (2) To demonstrate the role of 3D models in resident education. (3) To present future potential applications of 3D technology in ear, nose, and throat clinical and surgical practice.
Methods: Case report, review of literature, description of manufacturing workflow, and presentation of potential new education paradigm.
Results: A 73-year-old man sustained a penetrating facial trauma when the receiver of his black powder pistol backfired, penetrating through his left maxilla, orbit, infratemporal fossa, and into his lateral neck. Resultant injuries included bilateral Le Fort I fractures, left zygomaticomaxillary complex fracture, left orbital floor fracture, and left orbital rim fracture. Volumetric computed tomography and magnetic resonance images were obtained, and 3D images were prepared using commercially available software. A polylactic acid 3D model was printed at 0.1-mm spatial resolution within 16 hours. The monomaterial print was a destructible model, allowing free fragments to be mobilized and reconstruction simulated. This model was used perioperatively for resident education to better understand anatomy and pathology in preparation for surgical management.
Conclusions: Three-dimensional printing is a new technology that allows for the development of physical models that can help resident clinicians better understand patient-specific anatomy and pathology.
3d Printing and Preoperative Planning in Acute Midface Trauma Jeffrey A. Dorrity, MD (presenter); Rick Odland, MD, PhD
Objectives: (1) To demonstrate the use of an in-house 3-dimensional (3D) printer for preoperative planning, 3D modeling, and preoperative plate bending in acute midface trauma. (2) To use the 3D modeling and preoperative planning as a tool for resident education.
Methods: Retrospective chart review. Reviewing 4 cases from September 2015 to December 2016 for which an inhouse 3D printer was used for preoperative planning, 3D modeling, and preoperative plate bending in acute midface trauma. In the 3D model preoperative planning group, a patient's computed tomography scan, demonstrating the
